Loading…

Novo Nordisk officially opened its first tablet production facility in Måløv, Denmark, on June 26, 2018. The plant will produce semaglutide tablets for type 2 diabetes patients.
“I dag er en stor dag både for mennesker med type 2-diabetes og for os som virksomhed.”ing.dk
Summarized from public sources; check the original articles before acting on it.